{"id":45921,"date":"2022-07-07T16:02:03","date_gmt":"2022-07-07T14:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/"},"modified":"2022-07-07T16:02:03","modified_gmt":"2022-07-07T14:02:03","slug":"monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/","title":{"rendered":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5612478\/monoclonal-antibodies-for-oncology-global-markets?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=lpfzm3&amp;utm_campaign=1722855+-+Monoclonal+Antibodies+for+Oncology+Global+Market+Report+2022%3A+Featuring+Key+Players+GlaxoSmithKline%2C+AstraZeneca%2C+Merck+%26+Others&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Monoclonal Antibodies for Oncology: Global Markets&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market&#8217;s drivers, challenges, and opportunities.\n<\/p>\n<p>\nThe report also covers market projections to 2027 and market share for key market players. The report details the market share of monoclonal antibodies for oncology based on type and application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.\n<\/p>\n<p>\n<strong>Report Includes<\/strong>\n<\/p>\n<ul>\n<li>\nA brief general outlook of the global monoclonal antibodies for oncology market\n<\/li>\n<li>\nAnalyses of the global market trends, with market revenue (sales data) for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027\n<\/li>\n<li>\nHighlights of the current and future market potential of monoclonal antibodies for oncology treatment, and areas of focus to forecast this market into various segments and sub-segments\n<\/li>\n<li>\nEvaluation of the actual market size for monoclonal antibodies in oncology treatment, forecasted growth trends, and corresponding market share analysis by type of antibody, application area, and region\n<\/li>\n<li>\nTechnology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2022 to 2027)\n<\/li>\n<li>\nIn-depth information on increasing investments on R&amp;D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market\n<\/li>\n<li>\nReview of the patent landscape and new developments in the market for monoclonal antibodies for oncology and associated clinical trials\n<\/li>\n<li>\nIdentification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 Summary and Highlights<\/strong>\n<\/p>\n<p>\n<strong>Chapter 3 Market and Technology Background<\/strong>\n<\/p>\n<ul>\n<li>\nMonoclonal Antibodies\n<\/li>\n<li>\nHistory of Monoclonal Antibodies\n<\/li>\n<li>\nAdvantages and Disadvantages of Monoclonal Antibodies\n<\/li>\n<li>\nMonoclonal Antibodies in Oncology\n<\/li>\n<li>\nTypes of Monoclonal Antibodies\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 4 Market Dynamics<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Drivers\n<\/li>\n<li>\nIncreasing Incidence of Cancer\n<\/li>\n<li>\nNew Product Launches\n<\/li>\n<li>\nRising Healthcare Expenditures and Government Funding\n<\/li>\n<li>\nLicensing and Collaboration Agreements\n<\/li>\n<li>\nMarket Barriers\n<\/li>\n<li>\nPrice Controls\n<\/li>\n<li>\nRegulatory Approval Pressures\n<\/li>\n<li>\nEntry of Biosimilars\n<\/li>\n<li>\nOpportunities\n<\/li>\n<li>\nImpact of Covid-19\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 5 Market Breakdown by Type<\/strong>\n<\/p>\n<ul>\n<li>\nTypes of Monoclonal Antibodies for Oncology\n<\/li>\n<li>\nMarket Overview\n<\/li>\n<li>\nMarket Revenue\n<\/li>\n<li>\nGlobal Market for Monoclonal Antibodies in Oncology by Type\n<\/li>\n<li>\nHumanized Monoclonal Antibodies\n<\/li>\n<li>\nHuman Monoclonal Antibodies\n<\/li>\n<li>\nChimeric Monoclonal Antibodies\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 6 Market Breakdown by Application<\/strong>\n<\/p>\n<ul>\n<li>\nOverview\n<\/li>\n<li>\nLung Cancer\n<\/li>\n<li>\nMarket Size and Forecast\n<\/li>\n<li>\nBreast Cancer\n<\/li>\n<li>\nMarket Size and Forecast\n<\/li>\n<li>\nColorectal Cancer\n<\/li>\n<li>\nMarket Size and Forecast\n<\/li>\n<li>\nBlood Cancer\n<\/li>\n<li>\nMarket Size and Forecast\n<\/li>\n<li>\nOther Cancers\n<\/li>\n<li>\nMarket Size and Forecast\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 7 Market Breakdown by Region<\/strong>\n<\/p>\n<p>\n<strong>Chapter 8 Regulatory Aspects<\/strong>\n<\/p>\n<ul>\n<li>\nNew Approvals of Monoclonal Antibodies for Oncology\n<\/li>\n<li>\nRecalls, Withdrawals, and Safety Alerts\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 9 Patent Review\/ New Developments<\/strong>\n<\/p>\n<ul>\n<li>\nNew Developments\n<\/li>\n<li>\nPhase I Clinical Trials\n<\/li>\n<li>\nPhase II Clinical Trials\n<\/li>\n<li>\nPhase III Clinical Trials\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 10 Competitive Landscape<\/strong>\n<\/p>\n<ul>\n<li>\nMergers, Acquisitions, and Collaborations\n<\/li>\n<li>\nCompany Market Shares\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nAstraZeneca Pharmaceuticals\n<\/li>\n<li>\nBristol-Myers Squibb\n<\/li>\n<li>\nEli Lilly\n<\/li>\n<li>\nF. Hoffmann-La Roche AG\n<\/li>\n<li>\nGlaxoSmithKline\n<\/li>\n<li>\nGilead Sciences Inc.\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nMerck &amp; Co. Inc.\n<\/li>\n<li>\nMerck Kgaa\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi S.A.\n<\/li>\n<li>\nSeagen\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5612478\/monoclonal-antibodies-for-oncology-global-markets?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=lpfzm3&amp;utm_campaign=1722855+-+Monoclonal+Antibodies+for+Oncology+Global+Market+Report+2022%3A+Featuring+Key+Players+GlaxoSmithKline%2C+AstraZeneca%2C+Merck+%26+Others&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/5mtufb<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;r&#x65;s&#x73;&#64;&#x72;e&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;a&#x72;k&#x65;t&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;s&#x40;r&#101;&#x73;&#101;&#x61;r&#x63;h&#97;&#x6e;&#100;&#x6d;a&#x72;k&#101;&#x74;&#115;&#x2e;c&#x6f;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies for Oncology: Global Markets&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market&#8217;s drivers, challenges, and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45921","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies for Oncology: Global Markets&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market&#8217;s drivers, challenges, and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-07T14:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-07T14:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005460\\\/en\\\/1507142\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/\",\"name\":\"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005460\\\/en\\\/1507142\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-07T14:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005460\\\/en\\\/1507142\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005460\\\/en\\\/1507142\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies for Oncology: Global Markets&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market&#8217;s drivers, challenges, and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-07T14:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-07T14:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/"},"wordCount":599,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/","name":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg","datePublished":"2022-07-07T14:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220707005460\/en\/1507142\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/monoclonal-antibodies-for-oncology-global-market-report-2022-featuring-key-players-glaxosmithkline-astrazeneca-merck-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck &amp; Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45921"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45921\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}